ProQR Therapeutics (PRQR) FCF Margin Growth (5y) (2018 - 2026)
ProQR Therapeutics (PRQR) FCF Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47,510.00 |
| Dec 31, 2025 | -25,861.00 |
| Sep 30, 2025 | -33,078.00 |
| Jun 30, 2025 | -1,370.00 |
| Mar 31, 2025 | -36,725.00 |
| Dec 31, 2024 | -27,473.00 |
| Sep 30, 2024 | -7,476.00 |
| Jun 30, 2024 | -2,210.00 |
| Mar 31, 2024 | -24,122.00 |
| Dec 31, 2023 | -17,386.00 |
| Sep 30, 2023 | -51,762.00 |
| Jun 30, 2023 | -82,276.00 |
| Mar 31, 2023 | 682,153.00 |
| Dec 31, 2022 | -267,536.00 |
| Sep 30, 2022 | -185,725.00 |
| Jun 30, 2022 | -147,504.00 |
| Mar 31, 2022 | -183,292.00 |
| Dec 31, 2021 | 226,903.00 |
| Sep 30, 2021 | -90,379.00 |
| Dec 31, 2020 | 24,166.00 |